| Fill out the form below and press the "Send" link to send a message with a link to the following page. |
|
|
UH Harrington-McLaughlin Heart & Vascular Institute logo
In the News
University Hospitals Harrington-McLaughlin Heart & Vascular surgeon discusses H1N1 (article and video) Wednesday, November 11, 2009 (91 reads)
On one floor of University Hospitals Case Medical Center in Cleveland, the H1N1 virus is showing just how random, powerful and destructive it can be, even for healthy adults in the prime of their lives. Walter Savitts, 44, depends on a machine for every breath. His wife, Margaret, is constantly at his side. In the next hospital room, 34-year-old Robert Bradbury floated in and out of consciousness. Except for an asthma attack six years ago, he had been healthy and strong before the virus took hold. Dr. Arie Blitz, a heart surgeon for UH Harrington-McLaughlin Heart & Vascular Institute who treated both men, is featured on ABC’s Nightline discussing their conditions. Watch the video.
Read More |
The body’s little helper: tiny implanted device could help those with drug-resistant hypertension Thursday, November 05, 2009 (68 reads)
Drug-resistant hypertension could be a thing of the past, thanks partly to Alan Majni of Willoughby. As part of a clinical trial, Majni had a tiny iPod Nano-sized device, which works a bit like a pacemaker, implanted near his collarbone. The device sends a signal to his brain that his blood pressure is sky-high. The brain then controls functions in his body that can help bring the blood pressure under control, leaving drugs out of the equation. Thirty medical centers across the country are recruiting 300 people to try to demonstrate that the Rheos Baroreflex Hypertension Therapy System is safe to use in the general population. University Hospitals Harrington-McLaughlin Heart & Vascular Institute is the only one in this area, and Majni is part of the local study led by Dr. John Blebea, Chief, Division of Vascular Surgery & Endovascular Therapy.
Read More |